Share

Cardiotoxic synergism

Cardiotoxic synergism between anthracyclines, hypomethylating agents, and aminopeptidase inhibitors

Project objectives

Optimization of dosage and sequencing of anthracyclines and hypomethylating agents in patients with solid or hematologic tumors and candidates for subsequent treatment with aminopeptidase inhibitors.

Start and end date

2014 - 2015

Project Manager

Prof. Girogio Minotti, Head of Pharmaceutical Sciences UR, Campus Bio-Medico University and Campus Bio-Medico University Polyclinic Foundation, Rome - Principal Investigator
prof Emanuela Salvatorelli, UR Pharmaceutical Sciences, Campus Bio-Medico University, Rome

Coordinating institution of the project

UR Pharmaceutical Sciences, Departmental Faculty of Medicine and Surgery, Integrated Research Center, Campus Bio-Medico University, Rome

Funding source(s).

Sponsored study
QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right